Investor profile
Grand Pharma has backed 3 European tech companies across 3 funding rounds between 2022 and 2023, joining rounds totalling €120M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| InnovHeart | Italy | 1 | €49M |
| eTheRNA | Belgium | 1 | €39M |
| Xeltis | Switzerland | 1 | €32M |
